Luana Stanescu: Nothing to Disclose, Bin Zhang: Nothing to Disclose, Alexander Miethke: Mirum Pharmaceutical Inc: Grant/Research Support, Mirum Pharmaceutical Inc: Consultant, Ipsen: Speaking and Teaching, Jonathan Dillman: GE HealthCare: Grant/Research Support, Philips Healthcare: Grant/Research Support, Motilent: Grant/Research Support, Perspectum: Grant/Research Support, Andrew Trout: Siemens Healthineers: Funding to institution, GE Healthcare: Funding to institution, GE Healthcare: Expert review of images, Perspectum Inc: Funding to institution 2343 SPATIAL HETEROGENEITY OF LIVER STIFFNESS BY MR ELASTOGRAPHY IN PATIENTS WITH PRIMARY SCLEROSIS CHOLANGITIS DOES NOT ASSOCIATE WITH CLINICAL OUTCOMES Erick Cruz Grave 1 Connie Chan 1 Michael Corwin 1 Richard Dean 1 Sandeep Dhaliwal 1 Maryam Yazdanfar 1 Christopher Bowlus 1 , 1 University of California, Davis Background: Primary sclerosing cholangitis (PSC) is a cholestatic liver disease that progresses to cirrhosis and liver failure
IT IS CRUCIAL TO PREVENT LIPOSOMAL GLUTATHIONE FROM EXCESSIVE HEAT EXPOSURE
On the basis of the literature reports and on our data, we believe that an unaware probe end-user could encounter artificially attributed high values of GSH that are arising instead from both GSH and Cys, including Cys-protein residues
We believe that GSHee could be added to this exciting list
Short-term treatment with liraglutide lowered ANG II concentrations by 21% and limited sodium reabsorption in the proximal renal tubules
It is a tripeptide, which is a fancy way of saying it is made up of three specific amino acids: glutamine, cysteine, and glycine
